David Holland

This profile gathers the share dealings of David Holland in Alimera Sciences Inc, where the filings describe the role as senior executive. The record holds 21 filings, for trades running from 30 September 2019 to 16 September 2024.

No open-market sale appears; the market trades are 1 purchase worth €18k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 19 share grants.

The record was last updated on 18 September 2024 with a transaction in Alimera Sciences Inc. The last purchase on record was published on 4 November 2021, which is 1,815 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.